Sonothrombolysis: a universally applicable and better way to treat acute myocardial infarction and stroke? Who is going to fund the research?
Kaul
Sanjiv
S
D000818:Animals; D020520:Brain Infarction / Q000188:drug therapy / Q000453:epidemiology / Q000628:therapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005381:Financing, Organized; D006291:Health Policy; D006297:Health Services Accessibility; D006801:Humans; D045423:Microbubbles; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000453:epidemiology / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000295:instrumentation / Q000379:methods*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D012109:Research Support as Topic; D034421:Sus scrofa; D015912:Thrombolytic Therapy; D014159:Transducers / Q000600:supply & distribution; D016896:Treatment Outcome; D014464:Ultrasonic Therapy / Q000191:economics* / Q000295:instrumentation / Q000379:methods; D017585:Ultrasonography, Doppler, Transcranial / Q000295:instrumentation; D014481:United States
D005343:Fibrinolytic Agents; D019039:Platelet Glycoprotein GPIIb-IIIa Complex